0001807611-20-000001.txt : 20200408 0001807611-20-000001.hdr.sgml : 20200408 20200408104022 ACCESSION NUMBER: 0001807611-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200408 DATE AS OF CHANGE: 20200408 EFFECTIVENESS DATE: 20200408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Regenacy Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001807611 IRS NUMBER: 611807806 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-364531 FILM NUMBER: 20781381 BUSINESS ADDRESS: STREET 1: 303 WYMAN STREET STREET 2: SUITE 300 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-415-5030 MAIL ADDRESS: STREET 1: 303 WYMAN STREET STREET 2: SUITE 300 CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0708 D LIVE 0001807611 Regenacy Pharmaceuticals, Inc. 303 WYMAN STREET SUITE 300 WALTHAM MA MASSACHUSETTS 02451 617-415-5030 DELAWARE Regenacy Pharmaceuticals, LLC None Corporation true 2016 Simon Jones c/o Regenacy Pharmaceuticals, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Executive Officer Director President and Chief Executive Officer Marc Cohen c/o Regenacy Pharmaceuticals, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Executive Officer Director Secretary, Treasurer and Executive Chair John Rocha c/o Regenacy Pharmaceuticals, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Executive Officer Chief Financial Officer Michael L. Huang c/o Regenacy Pharmaceuticals, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Director Daguang Wang c/o Regenacy Pharmaceuticals, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Director Shixiang Yan c/o Regenacy Pharmaceuticals, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Director William Chin c/o Regenacy Pharmaceuticals, Inc. 303 Wyman Street, Suite 300 Waltham MA MASSACHUSETTS 02451 Director Pharmaceuticals Decline to Disclose 06b false 2020-03-24 false true false 0 Locust Walk Partners, LLC 156174 None None 200 Clarendon Street 51st Floor Boston MA MASSACHUSETTS 02116 All States true 40707421 20857418 19850003 A portion of the total amount sold includes the conversion of Promissory Notes. false 19 757500 true 0 Subject to future contingencies. 0 false Regenacy Pharmaceuticals, Inc. /s/ Simon Jones Simon Jones President & Chief Executive Officer 2020-04-08